Hunter Holt, MD, MAS

Assistant Professor
Contact: |

Hunter Holt, MD MAS is a board-certified family medicine physician and assistant professor in the UIC Department of Family and Community Medicine. Dr. Holt is focused on researching and implementing solutions that improve patient experiences and health outcomes related to reproductive health and cervical cancer prevention. In medical school, at Rush University, Dr. Holt traveled to China as a NIH Fogarty Global Health Fellow to research cervical cancer prevention in China. Working with the Cancer Institute of China, Dr.  Holt investigated cervical cancer screening in Chinese migrant workers and post-menopausal Chinese women. As a family medicine resident at the University of Illinois, Chicago, Dr. Holt was a part of the Global Health Track working in Senegal to implement sustainable solutions for cervical cancer prevention in rural Senegal. As a Primary Care Research Fellow at UCSF, Dr. Holt completed his master’s degree in Clinical and Epidemiological Research and worked to understand the reasons behind disparities in cervical cancer incidence and mortality. Currently Dr. Holt is working to finding solutions to reduce these cervical cancer disparities and promote health equity.



Original Research (Peer-Reviewed)

Schrier E*, Holt HK*, Kuppermann M, Sawaya GF (2022) Changing preferences for a cervical cancer screening strategy: moving away from annual testing, Women’s Health Report 3:1, 709–717, DOI: 10.1089/whr.2022.0007.

Holt HK, Gildengorin G, Karliner L, Fontil V, Pramanik R, Potter MB. Differences in Hypertension Medication Prescribing for Black Americans and Their Association with Hypertension Outcomes. The Journal of the American Board of Family Medicine. 2022;35(1):26-34. doi:10.3122/jabfm.2022.01.210276

Qin J, Shahangian S, Saraiya M, Holt HK, Gagnon M, Sawaya GF. Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013–2019. Gynecologic Oncology. 2021/09/08/ 2021;doi:

Sawaya GF, Holt HK, Lamar R, Perron-Burdick M, Smith-McCune K. Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California. Preventive medicine. 2021/10/01/ 2021;151:106569. doi:

Holt HK*, Zhang X*, Hu SY, Zhao FH, Smith JS, Qiao YL. Inequalities in Cervical Cancer Screening Uptake Between Chinese Migrant Women and Local Women: A Cross-Sectional Study. Cancer Control. 2021 Jan-Dec;28:1073274820985792. doi: 10.1177/1073274820985792. PMID: 33517761.

Holt HK, Sawaya GF, El Ayadi AM, Henderson JT, Rocca CH, Westhoff CL Harper CC. Unnecessary pelvic examinations: A barrier to contraception among survivors of intimate partner violence. J Gen Intern Med. 2020 Nov 3. doi: 10.1007/s11606-020-06334-8. Epub ahead of print. PMID: 33145695.

Holt HK, Kulasingam S, Sanstead EC, Alarid-Escudero F, Smith-McCune K, Gregorich SE, Silverberg MJ, Huchko MJ, Kuppermann M, Sawaya GF. Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations between Patients and Providers. MDM Policy & Practice 5(2): 2381468320952409

Peterson CE, Silva A, Holt HK, Balanean A, Goben AH, Dykens JA. Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review [published online ahead of print, 2020 Jun 14]. Cancer Causes Control. 2020;10.1007

Bichell TJV, Wegrzynowicz M, Tipps KG, Bradley EM, Uhouse MA, Bryan M, Horning K, Fisher N, Dudek K, Halbesma T, Umashanker P, Stubbs AD, Holt HK, Kwakye GF, Tidball AM, Colbran RJ, Aschner M, Neely MD, Di Pardo A, Maglione V, Osmand A, Bowman AB. Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington’s disease mouse model. Biochim Biophys Acta. 2017 Jun;1863(6):1596-1604.

Yang Z*, Holt HK*, Fan JH, Ma L, Liu Y, Chen W, Como P, Zhang L, Qiao YL. Optimal Cutoff Scores for Alzheimer’s Disease Using the Chinese Version of Mini-Mental State Examination Among Chinese Population Living in Rural Areas. Am J Alzheimers Dis Other Demen. 2016 Dec;31(8):650-657.

Han Y, Li S, Holt HK, Wu LY. Curative effect of bevacizumab combined with chemotherapy in advanced or recurrent uterine sarcoma. Mol Clin Oncol. 2016 Feb;4(2):245-248.

Wegrzynowicz M, Bichell TJ, Soares BD, Loth MK, McGlothan JS, Mori S, Alikhan FS, Hua K, Coughlin JM, Holt HK, Jetter CS, Pomper MG, Osmand AP, Guilarte TR, Bowman AB. Novel BAC Mouse Model of Huntington’s Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype. J Huntingtons Dis. 2015;4(1):17-36.

Wegrzynowicz M, Holt HK, Friedman DB, Bowman AB. Changes in the Striatal Proteome of YAC128Q Mice Exhibit Gene-Environment Interactions between Mutant Huntingtin and Manganese. J Proteome Res 2012; 11(2): 1118-32.

Johnson AK, Holt HK, Serici AJ, Moftakhar R. Trans-sphenoidal approach to the supraclinoid internal carotid artery for endovascular access in a cadaver. Neurointervention 2013;8:1-4

*Contributed Equally/Co-First Author